> top > docs > PMC:7784824 > spans > 16958-19217 > annotations

PMC:7784824 / 16958-19217 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
271 562-572 Species denotes SARS-CoV-2 Tax:2697049
363 322-330 Species denotes patients Tax:9606
364 422-427 Species denotes human Tax:9606
365 428-441 Species denotes coronaviruses Tax:11118
367 908-916 Species denotes patients Tax:9606
368 959-967 Species denotes patients Tax:9606
369 1089-1099 Species denotes SARS-CoV-2 Tax:2697049
370 1632-1640 Species denotes patients Tax:9606
371 1131-1141 Species denotes SARS-CoV-2 Tax:2697049
372 313-321 Disease denotes COVID-19 MESH:C000657245
373 899-907 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T184 0-94 Sentence denotes Recently, the first studies evaluating several commercial serology assays have been published.
T185 95-209 Sentence denotes Geurts van Kessel et al [17]. studied three rapid tests, four ELISAs and a high throughput chemiluminescent assay.
T186 210-331 Sentence denotes Sensitivity ranging from 81–100% was calculated by using a total of 187 sera from 107 RT-PCR confirmed COVID-19 patients.
T187 332-505 Sentence denotes Specificity was determined using 147 serum and plasma samples from individuals exposed to human coronaviruses and other respiratory viruses with values ranging from 85–100%.
T188 506-722 Sentence denotes Similar to our findings, the performance of the Liaison SARS-CoV-2 S1/S2 IgG (DiaSorin) was worst with a sensitivity of 81% (compared to 59% in our results) and specificity of 90% (compared with 100% in our results).
T189 723-968 Sentence denotes The group of Haselmann et al [16]. evaluated the performance of two IgG ELISA assays and one IgG electrochemiluminescence immunoassay (ECLIA) based on 51 serum samples from 26 COVID-19 patients and another 51 serum samples from control patients.
T190 969-1032 Sentence denotes They report a sensitivity of 92–100% and specificity of 84–96%.
T191 1033-1356 Sentence denotes The Austrian Red Cross Blood Service [15] evaluated 100 SARS-CoV-2 convalescent plasma donors and SARS-CoV-2 antibodies were characterized using three different IgG-ELISAs (EUROIMMUN IgG and NCP-IgG ELISA, Wantai ELISA), two CLIA (Elecsys, LIAISON) and two lateral flow tests (MEDsan IgM/IgG-Rapid-Test, Wantai Rapid Test).
T192 1357-1467 Sentence denotes The Wantai ELISA and the Elecsys provided the highest sensitivities in this sample (98 and 95 % respectively).
T193 1468-1680 Sentence denotes Serrano et al [18]. compared the performance of 3 lateral flow immunoassays (IgM/IgG combined) to 2 ELISAs (IgA and IgG) in serum samples from 109 RT-PCR confirmed patients in different weeks after symptom onset.
T194 1681-1755 Sentence denotes The IgA ELISA was most sensitive the first week after symptom onset (71%).
T195 1756-1821 Sentence denotes The sensitivity improved to 97% for IgA ELISA in the second week.
T196 1822-1923 Sentence denotes In the third week IgA ELISA, IgG ELISA and 2 out 3 IgG lateral flow tests had a sensitivity of > 96%.
T197 1924-1983 Sentence denotes The lateral flow immunoassays showed variable performances.
T198 1984-2115 Sentence denotes Pieri et al. also found that IgA detected by the ELISA assay might be a more reliable and stable early serological marker than IgM.
T199 2116-2202 Sentence denotes Instead, IgG, as expected, showed stable level after 10 days from symptoms onset [21].
T200 2203-2259 Sentence denotes These findings are in accordance with our study results.